ExodusPoint Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.44M | Buy |
126,515
+62,174
| +97% | +$4.64M | 0.08% | 220 |
|
2025
Q1 | $4.09M | Buy |
64,341
+49,898
| +345% | +$3.17M | 0.04% | 439 |
|
2024
Q4 | $1.13M | Sell |
14,443
-66,500
| -82% | -$5.19M | 0.01% | 834 |
|
2024
Q3 | $6.51M | Buy |
80,943
+51,667
| +176% | +$4.15M | 0.04% | 288 |
|
2024
Q2 | $2.42M | Buy |
+29,276
| New | +$2.42M | 0.02% | 607 |
|
2023
Q3 | – | Sell |
-10,423
| Closed | -$887K | – | 1803 |
|
2023
Q2 | $887K | Sell |
10,423
-39,809
| -79% | -$3.39M | 0.01% | 1061 |
|
2023
Q1 | $4.16M | Buy |
50,232
+12,332
| +33% | +$1.02M | 0.03% | 496 |
|
2022
Q4 | $2.98M | Buy |
+37,900
| New | +$2.98M | 0.04% | 484 |
|
2022
Q1 | – | Sell |
-5,726
| Closed | -$304K | – | 2303 |
|
2021
Q4 | $304K | Buy |
+5,726
| New | +$304K | ﹤0.01% | 1615 |
|
2021
Q2 | – | Sell |
-6,015
| Closed | -$668K | – | 2450 |
|
2021
Q1 | $668K | Sell |
6,015
-32,473
| -84% | -$3.61M | 0.01% | 1120 |
|
2020
Q4 | $4.57M | Sell |
38,488
-14,171
| -27% | -$1.68M | 0.04% | 253 |
|
2020
Q3 | $4.59M | Buy |
52,659
+14,258
| +37% | +$1.24M | 0.09% | 165 |
|
2020
Q2 | $3.44M | Buy |
+38,401
| New | +$3.44M | 0.09% | 239 |
|
2020
Q1 | – | Sell |
-33,437
| Closed | -$3.84M | – | 1250 |
|
2019
Q4 | $3.84M | Buy |
+33,437
| New | +$3.84M | 0.07% | 165 |
|